After this training, the participant should feel more comfortable counseling their patients on the dangers of xylazine, a new compound that is in the white powder (opioids and stimulants) drug supply. This presentation emphasizes harm reduction in the setting of patients with substance use disorder, stressing that one can help someone who may not be ready for complete abstinence from harmful drug use.
- Appreciate appropriate use of xylazine and why it is not used in humans
- Learn the “street names” of xylazine
- Explore the prevalence of xylazine in Rhode Island
- Understand how to talk to your clients about xylazine
- Appreciate the subtle differences of what a xylazine overdose response should look like (specifically, when to use Naloxone and rescue breathing)
- Discuss wound care and safe injection practices to reduce harms from xylazine
Continuing Medical Education Credits:
For physicians who require a CME certificate, the certificate will be emailed directly to you 2-3 weeks after this course You must complete the survey within 2 weeks to receive your certificate. For all other professions, you can download and use the certificate provided within this course.
Online Course Evaluation: Instructions
After the live meeting ends:
- Log into this online course
- Click below on “Course Survey” to access the survey. After completing the survey, return to the course page.
- After you submit the evaluation, click Mark Complete and you will be able to download or print your certificate. The certificate will also be emailed to you as a PDF.
- If you need a certificate for Continuing Medical Education, you will be emailed a CME certificate within 2-3 weeks of the end of this course.